Blood Pressure Reduction with Chlorthalidone

Efficacy of Chlorthalidone

The American Journal of Kidney Diseases recommends chlorthalidone 25 mg daily for reducing 24-hour ambulatory blood pressure by 10.5 ± 3.1 mm Hg in patients with chronic kidney disease (CKD) 1, 2
Chlorthalidone is more effective than hydrochlorothiazide (HCTZ) at lowering blood pressure when comparing equivalent doses, as reported in Circulation Research 3
Chlorthalidone has been used in many major blood pressure trials and is considered superior to hydrochlorothiazide, particularly in advanced CKD, according to the American Journal of Kidney Diseases 1, 2

The equivalent dose of hydrochlorothiazide for 25 mg of chlorthalidone is 50 mg, as stated in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4

Thiazide-like diuretics such as chlorthalidone can cause electrolyte abnormalities, particularly hypokalemia, as noted in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
Chlorthalidone has a higher risk of hypokalemia compared to equivalent doses of hydrochlorothiazide, according to Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
When initiating chlorthalidone, electrolyte levels and kidney function should be checked within 4 weeks of starting treatment, as recommended by the American Journal of Kidney Diseases 1, 2
Chlorthalidone is effective for blood pressure management even in patients with advanced CKD (eGFR < 30 mL/min/1.73 m²), as reported in the American Journal of Kidney Diseases 1, 2

Chlorthalidone 25 mg daily is an appropriate starting dose for most patients with hypertension, according to the American Journal of Kidney Diseases 1, 2
When converting from chlorthalidone to hydrochlorothiazide, a 1:2 ratio should be used (25 mg chlorthalidone ≈ 50 mg hydrochlorothiazide), as stated in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4